Results of the prospective EORTC Children Leukemia Group study 58081 in precursor B‐ and T‐cell acute lymphoblastic leukemia

Abstract Here, we report the results of the prospective cohort study EORTC‐CLG 58081 and compare them to the control arm of the randomized phase 3 trial EORTC‐CLG 58951, on which treatment recommendations were built. In both studies, patients aged 1–18 years with BCR::ABL1 negative acute lymphoblast...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Carine Domenech, Michal Kicinski, Barbara De Moerloose, Caroline Piette, Wadih A. Chahla, Laure Kornreich, Marlène Pasquet, Anne Uyttebroeck, Alexandre Theron, Marilyne Poirée, Chloé Arfeuille, Marleen Bakkus, Nathalie Grardel, Catherine Paillard, Claire Freycon, Frédéric Millot, Pauline Simon, Pierre Philippet, Claire Pluchart, Stefan Suciu, Pierre Rohrlich, Alina Ferster, Yves Bertrand, Hélène Cavé, for the Children's Leukemia Group (CLG) of the European Organization for Research and Treatment of Cancer (EORTC)
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2024-11-01
coleção:	HemaSphere
Acesso em linha:	https://doi.org/10.1002/hem3.70025
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!